Baird Starts Harpoon Therapeutics (HARP) at Outperform
Tweet Send to a Friend
Baird analyst Michael Ulz initiates coverage on Harpoon Therapeutics (NASDAQ: HARP) with a Outperform rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE